David M. Hockenbery
Affiliations: | University of Washington, Seattle, Seattle, WA |
Area:
Cell Biology, Molecular BiologyGoogle:
"David Hockenbery"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lindsay K, Brenner C, Hockenbery D, et al. (2019) CBMT-30. TARGETING NICOTINAMIDE ADENINE DINUCLEOTIDE BIOSYNTHESIS IN CNS TUMORS Neuro-Oncology. 21: vi39-vi39 |
| Bluestein BM, Morrish F, Graham DJ, et al. (2018) Analysis of the Myc-induced pancreatic cell islet tumor microenvironment using imaging ToF-SIMS. Biointerphases. 13: 06D402 |
| Nagana Gowda GA, Barding GA, Dai J, et al. (2018) A Metabolomics Study of BPTES Altered Metabolism in Human Breast Cancer Cell Lines. Frontiers in Molecular Biosciences. 5: 49 |
| Davis RJ, Gönen M, Margineantu DH, et al. (2018) Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism. Proceedings of the National Academy of Sciences of the United States of America |
| Steinbach G, Hockenbery DM, Huls G, et al. (2017) Pilot study of lithium to restore intestinal barrier function in severe graft-versus-host disease. Plos One. 12: e0183284 |
| Berger S, Procko E, Margineantu D, et al. (2016) Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer. Elife. 5 |
| Iwata TN, Ramírez JA, Tsang M, et al. (2016) Conditional Disruption of Raptor Reveals an Essential Role for mTORC1 in B Cell Development, Survival, and Metabolism. Journal of Immunology (Baltimore, Md. : 1950) |
| Margineantu DH, Hockenbery DM. (2016) Mitochondrial functions in stem cells. Current Opinion in Genetics & Development. 38: 110-117 |
| Aguilar E, Marin de Mas I, Zodda E, et al. (2016) Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program. Stem Cells (Dayton, Ohio). 34: 1163-76 |
| Berger S, Procko E, Margineantu D, et al. (2016) Author response: Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer Elife |